Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Hypertension"" wg kryterium: Temat


Starter badań:

Tytuł:
Transitioning intravenous epoprostenol to oral selexipag in idiopathic pulmonary arterial hypertension: a case report.
Autorzy:
Alexandre A; Department of Cardiology, Centro Hospitalar Universitário de Santo António (CHUdSA), Porto, Portugal.
Furtado I; Pulmonary Vascular Disease Unit, Centro Hospitalar Universitário de Santo António (CHUdSA), Porto, Portugal.; Department of Internal Medicine, Centro Hospitalar Universitário de Santo António (CHUdSA), Porto, Portugal.
Carvalho L; Pulmonary Vascular Disease Unit, Centro Hospitalar Universitário de Santo António (CHUdSA), Porto, Portugal.; Department of Internal Medicine, Centro Hospitalar Universitário de Santo António (CHUdSA), Porto, Portugal.
Gonçalves F; Pulmonary Vascular Disease Unit, Centro Hospitalar Universitário de Santo António (CHUdSA), Porto, Portugal.; Department of Internal Medicine, Centro Hospitalar Universitário de Santo António (CHUdSA), Porto, Portugal.; ICBAS-School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal.
Melo A; Pulmonary Vascular Disease Unit, Centro Hospitalar Universitário de Santo António (CHUdSA), Porto, Portugal.
Alves J; Pulmonary Vascular Disease Unit, Centro Hospitalar Universitário de Santo António (CHUdSA), Porto, Portugal.
Santos M; Department of Cardiology, Centro Hospitalar Universitário de Santo António (CHUdSA), Porto, Portugal.; Pulmonary Vascular Disease Unit, Centro Hospitalar Universitário de Santo António (CHUdSA), Porto, Portugal.; ICBAS-School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal.; ITR-Laboratory for Integrative and Translational Research in Population Health, Porto, Portugal.; UMIB-Unit for Multidisciplinary Research in Biomedicine, ICBAS-School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal.
Reis A; Pulmonary Vascular Disease Unit, Centro Hospitalar Universitário de Santo António (CHUdSA), Porto, Portugal.; Department of Internal Medicine, Centro Hospitalar Universitário de Santo António (CHUdSA), Porto, Portugal.; ICBAS-School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal.
Pokaż więcej
Źródło:
ESC heart failure [ESC Heart Fail] 2023 Aug; Vol. 10 (4), pp. 2722-2727. Date of Electronic Publication: 2023 Jun 19.
Typ publikacji:
Case Reports
MeSH Terms:
Hypertension, Pulmonary*
Pulmonary Arterial Hypertension*/drug therapy
Female ; Humans ; Middle Aged ; Epoprostenol/therapeutic use ; Antihypertensive Agents/therapeutic use ; Familial Primary Pulmonary Hypertension/chemically induced ; Familial Primary Pulmonary Hypertension/drug therapy
Raport
Tytuł:
Metabolomics in Pulmonary Hypertension-A Useful Tool to Provide Insights into the Dark Side of a Tricky Pathology.
Autorzy:
Bassareo PP; Mater Misercordiae University Hospital, D07 R2WY Dublin, Ireland.; Children's Health Ireland at Crumlin, D12 N512 Dublin, Ireland.; School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland.
D'Alto M; Pulmonary Hypertension Unit, Dipartimento di Cardiologia, Università della Campania 'Luigi Vanvitelli', Ospedale Monaldi, 80131 Naples, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Aug 25; Vol. 24 (17). Date of Electronic Publication: 2023 Aug 25.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Hypertension, Pulmonary*
Pulmonary Arterial Hypertension*
Body Fluids*
Humans ; Metabolomics ; Familial Primary Pulmonary Hypertension
Czasopismo naukowe
Tytuł:
Therapeutic effects of hypoxia-preconditioned bone marrow-derived mesenchymal stromal cells and their extracellular vesicles in experimental pulmonary arterial hypertension.
Autorzy:
Braga CL; Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, Brazil.
Santos RT; Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
da Silva CM; Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
de Novaes Rocha N; Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, Brazil; Department of Physiology and Pharmacology, Biomedical Institute, Fluminense Federal University, Niteroi, Brazil.
Felix NS; Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Medeiros M; Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Melo MM; Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Silva JD; Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, Brazil.
Teixeira DE; Laboratory of Biochemistry and Cell Signaling, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, RJ, Brazil.
Neves CC; National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, Brazil; Laboratory of Biochemistry and Cell Signaling, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, RJ, Brazil.
Rocco PRM; Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, Brazil.
Cruz FF; Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, Brazil.
Silva PL; Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, Brazil. Electronic address: .
Pokaż więcej
Źródło:
Life sciences [Life Sci] 2023 Sep 15; Vol. 329, pp. 121988. Date of Electronic Publication: 2023 Jul 29.
Typ publikacji:
Journal Article
MeSH Terms:
Hypertension, Pulmonary*
Pulmonary Arterial Hypertension*/therapy
Pulmonary Arterial Hypertension*/metabolism
Extracellular Vesicles*/metabolism
Mesenchymal Stem Cells*/metabolism
Rats ; Animals ; Male ; Hypertrophy, Right Ventricular ; Bone Marrow/metabolism ; Cells, Cultured ; Rats, Wistar ; Familial Primary Pulmonary Hypertension ; Collagen/metabolism ; Hypoxia/metabolism
Czasopismo naukowe
Tytuł:
A prognostic model for systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study.
Autorzy:
Qu J; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science and Technology, No. 1 Shuaifuyuan, Wangfujing Ave, Beijing, 100730, China.; Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
Li M; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science and Technology, No. 1 Shuaifuyuan, Wangfujing Ave, Beijing, 100730, China. .
Zhang X; Department of Rheumatology, Guangdong General Hospital, Guangzhou, China.
Zhang M; Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zuo X; Department of Rheumatology, Xiangya Hospital, Central South University, Changsha, China.
Zhu P; Department of Clinical Immunology, PLA Specialized Research Institute of Rheumatology and Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Ye S; Department of Rheumatology, School of Medicine, Shanghai Jiao Tong University, Ren Ji Hospital South Campus, Shanghai, China.
Zhang W; Department of Rheumatology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China.
Zheng Y; Department of Rheumatology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Qi W; Department of Rheumatology, The First Central Hospital, Tianjin, China.
Li Y; Department of Rheumatology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Zhang Z; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
Ding F; Department of Rheumatology, Qilu Hospital of Shandong University, Jinan, China.
Gu J; Department of Rheumatology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Liu Y; Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.
Qian J; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science and Technology, No. 1 Shuaifuyuan, Wangfujing Ave, Beijing, 100730, China.
Huang C; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science and Technology, No. 1 Shuaifuyuan, Wangfujing Ave, Beijing, 100730, China.
Zhao J; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science and Technology, No. 1 Shuaifuyuan, Wangfujing Ave, Beijing, 100730, China.
Wang Q; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science and Technology, No. 1 Shuaifuyuan, Wangfujing Ave, Beijing, 100730, China.
Liu Y; Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science & Technology, Beijing, China.
Tian Z; Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science & Technology, Beijing, China.
Wang Y; Department of Epidemiology and Bio-Statistics, Institute of Basic Medical Sciences, China Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wei W; Department of Rheumatology, Tianjin Medical University General Hospital, No. 154 Anshan Street, Tianjin, 300052, China. .
Zeng X; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science and Technology, No. 1 Shuaifuyuan, Wangfujing Ave, Beijing, 100730, China. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2023 Sep 09; Vol. 24 (1), pp. 220. Date of Electronic Publication: 2023 Sep 09.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Pulmonary Arterial Hypertension*/diagnosis
Pulmonary Arterial Hypertension*/epidemiology
Pulmonary Arterial Hypertension*/etiology
Hypertension, Pulmonary*/diagnosis
Hypertension, Pulmonary*/epidemiology
Hypertension, Pulmonary*/etiology
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/diagnosis
Lupus Erythematosus, Systemic*/epidemiology
Humans ; Cohort Studies ; Prognosis ; Familial Primary Pulmonary Hypertension
Czasopismo naukowe
Tytuł:
Association of red cell distribution width with pulmonary arterial hypertension in patients with mixed connective tissue disease.
Autorzy:
Jin Y; Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, Jiangsu Province, 210008, China.; Department of Rheumatology and Immunology, Suzhou Wuzhong People's Hospital, 61 Dongwu North Road, Suzhou, Jiangsu Province, 215128, China.
Guo G; Department of Cardiology, Cardiac Function Room, The Affiliated Drum Tower Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, Jiangsu Province, 210008, China.
Wang C; Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, Jiangsu Province, 210008, China.
Jiang B; Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, Jiangsu Province, 210008, China. .
Pokaż więcej
Źródło:
BMC pulmonary medicine [BMC Pulm Med] 2023 Aug 14; Vol. 23 (1), pp. 299. Date of Electronic Publication: 2023 Aug 14.
Typ publikacji:
Journal Article
MeSH Terms:
Mixed Connective Tissue Disease*/complications
Pulmonary Arterial Hypertension*/complications
Hypertension, Pulmonary*
Humans ; Erythrocyte Indices ; Familial Primary Pulmonary Hypertension
Czasopismo naukowe
Tytuł:
Acid ceramidase gene therapy ameliorates pulmonary arterial hypertension with right heart dysfunction.
Autorzy:
Katz MG; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, 1470 Madison Ave, P.O. Box 1030, New York, NY, 10029-6574, USA.; Department of Pediatric Cardiac Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Hadas Y; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, 1470 Madison Ave, P.O. Box 1030, New York, NY, 10029-6574, USA.; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Vincek A; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, 1470 Madison Ave, P.O. Box 1030, New York, NY, 10029-6574, USA.
Freage-Kahn L; Aveta.Life, Hoboken, NJ, USA.
Shtraizent N; SeneX Therapeutics Inc., New York, NY, USA.
Madjarov JM; Atrium Health Sanger Heart and Vascular Institute, Charlotte, NC, USA.; Wake Forest School of Medicine, Winston-Salem, NC, USA.
Pastuszko P; Department of Pediatric Cardiac Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Eliyahu E; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, 1470 Madison Ave, P.O. Box 1030, New York, NY, 10029-6574, USA. .; Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2023 Aug 11; Vol. 24 (1), pp. 197. Date of Electronic Publication: 2023 Aug 11.
Typ publikacji:
Journal Article
MeSH Terms:
Pulmonary Arterial Hypertension*
Hypertension, Pulmonary*/genetics
Hypertension, Pulmonary*/therapy
Hypertension, Pulmonary*/pathology
Ventricular Dysfunction, Right*
Animals ; Acid Ceramidase/genetics ; Familial Primary Pulmonary Hypertension ; Genetic Therapy ; Pulmonary Artery/pathology
Czasopismo naukowe
Tytuł:
Outcomes of pregnancy in women with different types of pulmonary hypertension.
Autorzy:
Liu Y; Department of Pediatric Cardiac Center, Beijing Anzhen Hospital Affiliated to Capital Medical University, Chaoyang District, Beijing, China.
Li H; Department of Adult Cardiac Center, Beijing Anzhen Hospital Affiliated to Capital Medical University, Chaoyang District, Beijing, China.
Li Y; Department of Obstetrics and Gynecology, Beijing Anzhen Hospital Affiliated to Capital Medical University, Chaoyang District, Beijing, China.
Zhang J; Department of Obstetrics and Gynecology, Beijing Anzhen Hospital Affiliated to Capital Medical University, Chaoyang District, Beijing, China.
Gu H; Department of Pediatric Cardiac Center, Beijing Anzhen Hospital Affiliated to Capital Medical University, Chaoyang District, Beijing, China.
Wang J; Department of Adult Cardiac Center, Beijing Anzhen Hospital Affiliated to Capital Medical University, Chaoyang District, Beijing, China. .; Capital Medical University, Beijing Anzhen Hospital, No.2 An Zhen Road, Chaoyang District, Beijing, 100029, China. .
Wang Q; Department of Pediatric Cardiac Center, Beijing Anzhen Hospital Affiliated to Capital Medical University, Chaoyang District, Beijing, China. .; Capital Medical University, Beijing Anzhen Hospital, No.2 An Zhen Road, Chaoyang District, Beijing, 100029, China. .
Pokaż więcej
Źródło:
BMC cardiovascular disorders [BMC Cardiovasc Disord] 2023 Aug 09; Vol. 23 (1), pp. 391. Date of Electronic Publication: 2023 Aug 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hypertension, Pulmonary*/diagnosis
Hypertension, Pulmonary*/etiology
Infant, Newborn ; Child ; Pregnancy ; Female ; Humans ; Young Adult ; Adult ; Cesarean Section/adverse effects ; Retrospective Studies ; Pregnancy Outcome ; Familial Primary Pulmonary Hypertension ; Death
Czasopismo naukowe
Tytuł:
Efficacy of single-pill combination in uncontrolled essential hypertension: A systematic review and network meta-analysis.
Autorzy:
Xie M; Department of Cardiology, Dongguan Children's Hospital Affiliated to Guangdong Medical University, Shilong, Dongguan, China.
Tang T; Department of Cardiology, Dongguan Children's Hospital Affiliated to Guangdong Medical University, Shilong, Dongguan, China.
Liang H; Department of Cardiology, Dongguan Children's Hospital Affiliated to Guangdong Medical University, Shilong, Dongguan, China.
Pokaż więcej
Źródło:
Clinical cardiology [Clin Cardiol] 2023 Aug; Vol. 46 (8), pp. 886-898. Date of Electronic Publication: 2023 Jul 11.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Antihypertensive Agents*/therapeutic use
Hypertension*/diagnosis
Hypertension*/drug therapy
Humans ; Losartan/pharmacology ; Losartan/therapeutic use ; Telmisartan/pharmacology ; Telmisartan/therapeutic use ; Irbesartan/pharmacology ; Irbesartan/therapeutic use ; Angiotensin Receptor Antagonists/therapeutic use ; Network Meta-Analysis ; Hydrochlorothiazide/adverse effects ; Valine/adverse effects ; Drug Therapy, Combination ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Amlodipine/therapeutic use ; Valsartan/therapeutic use ; Tetrazoles/therapeutic use ; Blood Pressure ; Essential Hypertension/diagnosis ; Essential Hypertension/drug therapy ; Essential Hypertension/chemically induced
Czasopismo naukowe
Tytuł:
Maresin-1 protects against pulmonary arterial hypertension by improving mitochondrial homeostasis through ALXR/HSP90α axis.
Autorzy:
Liu M; Advanced Institute for Medical Sciences, Dalian Medical University, Dalian 116044, China.
He H; Advanced Institute for Medical Sciences, Dalian Medical University, Dalian 116044, China.
Fan F; Division of Pulmonary Vascular Disease, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Qiu L; Health Science Center, East China Normal University, Shanghai 200241, China.
Zheng F; Advanced Institute for Medical Sciences, Dalian Medical University, Dalian 116044, China.
Guan Y; Advanced Institute for Medical Sciences, Dalian Medical University, Dalian 116044, China.
Yang G; School of Bioengineering, Dalian University of Technology, Dalian 116024, China.
Chen L; Advanced Institute for Medical Sciences, Dalian Medical University, Dalian 116044, China; Health Science Center, East China Normal University, Shanghai 200241, China. Electronic address: .
Pokaż więcej
Źródło:
Journal of molecular and cellular cardiology [J Mol Cell Cardiol] 2023 Aug; Vol. 181, pp. 15-30. Date of Electronic Publication: 2023 May 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Pulmonary Arterial Hypertension*/metabolism
Hypertension, Pulmonary*/metabolism
Mice ; Rats ; Animals ; Heat-Shock Proteins/adverse effects ; Heat-Shock Proteins/metabolism ; Vascular Remodeling ; Cell Proliferation ; Cells, Cultured ; Familial Primary Pulmonary Hypertension ; Pulmonary Artery ; Hypoxia/metabolism ; Myocytes, Smooth Muscle/metabolism ; Monocrotaline ; Disease Models, Animal
Czasopismo naukowe
Tytuł:
Network meta-analysis of sacubitril/valsartan for the treatment of essential hypertension.
Autorzy:
Zhang Y; Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, China.
Zhao X; Department of Cardiovascular, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, China.
Huang H; Department of Cardiovascular, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, China. .
Li M; Department of Cardiovascular, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, China. .
Pokaż więcej
Źródło:
Clinical research in cardiology : official journal of the German Cardiac Society [Clin Res Cardiol] 2023 Jul; Vol. 112 (7), pp. 855-867. Date of Electronic Publication: 2022 Nov 03.
Typ publikacji:
Meta-Analysis; Journal Article; Review
MeSH Terms:
Angiotensin II Type 1 Receptor Blockers*/therapeutic use
Hypertension*/diagnosis
Hypertension*/drug therapy
Humans ; Network Meta-Analysis ; Tetrazoles/adverse effects ; Valsartan/pharmacology ; Essential Hypertension/chemically induced ; Essential Hypertension/drug therapy ; Antihypertensive Agents/therapeutic use ; Blood Pressure ; Drug Combinations ; Angiotensin Receptor Antagonists/adverse effects ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry.
Autorzy:
Garcia AR; Department of Pulmonary Medicine, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.; Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.
Blanco I; Department of Pulmonary Medicine, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.; Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.
Ramon L; Department of Pulmonary Medicine, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.; Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.
Pérez-Sagredo J; Department of Pulmonary Medicine, Hospital El Bierzo, León, Spain.
Guerra-Ramos FJ; Department of Pulmonary Medicine, Complejo Hospitalario Universitario Insular-Materno Infantil, Las Palmas, Spain.
Martín-Ontiyuelo C; Department of Pulmonary Medicine, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.; Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.
Tura-Ceide O; Department of Pulmonary Medicine, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.; Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.
Pastor-Pérez F; Cardiology Department, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Escribano-Subías P; Pulmonary Hypertension Unit, Cardiology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; Biomedical Research Networking Center on Cardiovascular Diseases (CIBERCV), Madrid, Spain.
Barberà JA; Department of Pulmonary Medicine, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain. .; Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2023 Sep 15; Vol. 24 (1), pp. 223. Date of Electronic Publication: 2023 Sep 15.
Typ publikacji:
Journal Article
MeSH Terms:
Pulmonary Arterial Hypertension*/diagnosis
Pulmonary Arterial Hypertension*/drug therapy
Pulmonary Arterial Hypertension*/epidemiology
HIV Infections*
Humans ; Male ; Cyclic Nucleotide Phosphodiesterases, Type 5 ; Phosphodiesterase 5 Inhibitors/therapeutic use ; Familial Primary Pulmonary Hypertension ; Registries
Czasopismo naukowe
Tytuł:
Plasma untargeted metabolomics with proteinase K discloses phospholipid signature associated with pulmonary arterial hypertension.
Autorzy:
Wawrzyniak R; Department of Biopharmaceutics and Pharmacodynamics, Medical University of Gdańsk, Hallera 107, 80-416, Gdańsk, Poland. .
Biesemans M; Department of Biopharmaceutics and Pharmacodynamics, Medical University of Gdańsk, Hallera 107, 80-416, Gdańsk, Poland.
Kugacka-Dąbrowska A; Department of Cardiology and Electrotherapy, Medical University of Gdansk, Debinki 7, 80-210, Gdańsk, Poland.
Lewicka E; Department of Cardiology and Electrotherapy, Medical University of Gdansk, Debinki 7, 80-210, Gdańsk, Poland.
Bartoszewski R; Department of Biophysics, Faculty of Biotechnology, University of Wroclaw, Ul. F. Joliot-Curie 14A, 50-383, Wrocław, Poland.
Markuszewski MJ; Department of Biopharmaceutics and Pharmacodynamics, Medical University of Gdańsk, Hallera 107, 80-416, Gdańsk, Poland.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Sep 15; Vol. 13 (1), pp. 15280. Date of Electronic Publication: 2023 Sep 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Pulmonary Arterial Hypertension*
Hypertension, Pulmonary*
Humans ; Endopeptidase K ; Familial Primary Pulmonary Hypertension ; Metabolomics ; Pulmonary Artery
Czasopismo naukowe
Tytuł:
Severe Pulmonary Arterial Hypertension in Healthy Young Infants: Single Center Experience.
Autorzy:
Aroor S; Department of Paediatrics, Kasturba Medical College (Manipal Academy of Higher Education), Manipal, Karnataka.
Handattu K; Department of Paediatrics, Kasturba Medical College (Manipal Academy of Higher Education), Manipal, Karnataka. Correspondence to: Dr Koushik Handattu, Assosciate Professor, Department of Pediatrics, Kasturba Medical College (Manipal Academy of Higher Education), Manipal, Karnataka. .
Mundkur SC; Department of Paediatrics, Kasturba Medical College (Manipal Academy of Higher Education), Manipal, Karnataka.
Verma A; Department of Paediatrics, Kasturba Medical College (Manipal Academy of Higher Education), Manipal, Karnataka.
Samuel PC; Department of Paediatrics, Kasturba Medical College (Manipal Academy of Higher Education), Manipal, Karnataka.
Teli AS; Department of Cardiology, Kasturba Medical College (Manipal Academy of Higher Education), Manipal, Karnataka.
Banga G; Department of Cardiology, Kasturba Medical College (Manipal Academy of Higher Education), Manipal, Karnataka.
Pokaż więcej
Źródło:
Indian pediatrics [Indian Pediatr] 2023 Sep 15; Vol. 60 (9), pp. 748-751. Date of Electronic Publication: 2023 May 30.
Typ publikacji:
Journal Article
MeSH Terms:
Hypertension, Pulmonary*/diagnosis
Pulmonary Arterial Hypertension*/drug therapy
Ventricular Dysfunction*/drug therapy
Humans ; Infant ; Aged ; Retrospective Studies ; Familial Primary Pulmonary Hypertension/drug therapy ; Vasodilator Agents/therapeutic use ; Thiamine/therapeutic use
Czasopismo naukowe
Tytuł:
Risk of dementia in primary aldosteronism compared with essential hypertension: a nationwide cohort study.
Autorzy:
Hong N; Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Yonsei University College of Medicine, 50-1 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Republic of Korea.
Kim KJ; Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
Yu MH; SENTINEL Team, Division of Endocrinology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
Jeong SH; Department of Neurology, Inje University Sanggye Paik Hospital, Seoul, Republic of Korea.
Lee S; Department of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, 20, Ilsan-Ro, Wonju-Si, Gangwon-Do, 26426, Republic of Korea.
Lim JS; Department of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, 20, Ilsan-Ro, Wonju-Si, Gangwon-Do, 26426, Republic of Korea. .
Rhee Y; Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Yonsei University College of Medicine, 50-1 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Republic of Korea. .
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2023 Aug 11; Vol. 15 (1), pp. 136. Date of Electronic Publication: 2023 Aug 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease*/complications
Dementia, Vascular*/complications
Hyperaldosteronism*/complications
Hyperaldosteronism*/epidemiology
Hyperaldosteronism*/diagnosis
Hypertension*/epidemiology
Humans ; Cohort Studies ; Essential Hypertension/drug therapy ; Essential Hypertension/epidemiology ; Essential Hypertension/chemically induced ; Mineralocorticoid Receptor Antagonists/adverse effects
Czasopismo naukowe
Tytuł:
Effects of olmesartan and amlodipine on blood pressure, endothelial function, and vascular inflammation.
Autorzy:
Honda A; Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan.
Tahara N; Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan. .
Tahara A; Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan.
Bekki M; Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan.
Maeda-Ogata S; Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan.
Sugiyama Y; Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan.
Igata S; Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan.
Nishino Y; Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume, Japan.
Matsui T; Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume, Japan.
Kurata S; Department of Radiology, Kurume University School of Medicine, Kurume, Japan.
Abe T; Department of Radiology, Kurume University School of Medicine, Kurume, Japan.
Yamagishi SI; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Fukumoto Y; Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan.
Pokaż więcej
Źródło:
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology [J Nucl Cardiol] 2023 Aug; Vol. 30 (4), pp. 1613-1626. Date of Electronic Publication: 2023 Feb 03.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Amlodipine*/pharmacology
Amlodipine*/therapeutic use
Hypertension*/diagnostic imaging
Hypertension*/drug therapy
Hypertension*/complications
Humans ; Middle Aged ; Aged ; Antihypertensive Agents/pharmacology ; Antihypertensive Agents/therapeutic use ; Blood Pressure ; Angiotensin Receptor Antagonists/pharmacology ; Angiotensin Receptor Antagonists/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Calcium Channel Blockers/pharmacology ; Calcium Channel Blockers/therapeutic use ; Essential Hypertension/complications ; Essential Hypertension/drug therapy ; Inflammation/diagnostic imaging ; Inflammation/complications ; Drug Therapy, Combination
Czasopismo naukowe
Tytuł:
Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients.
Autorzy:
Kondo T; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan. .; Ultrasound Center, Chiba University Hospital, Chiba, Japan. .
Fujiwara K; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Nakagawa M; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Fujimoto K; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Yumita S; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Ishino T; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Ogawa K; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Iwanaga T; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Koroki K; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Kanzaki H; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Inoue M; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Kobayashi K; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Kiyono S; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Nakamura M; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Kanogawa N; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Ogasawara S; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Nakamoto S; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Chiba T; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Kato J; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Kato N; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan.; Ultrasound Center, Chiba University Hospital, Chiba, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Jul 17; Vol. 13 (1), pp. 11524. Date of Electronic Publication: 2023 Jul 17.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/drug therapy
Pulmonary Arterial Hypertension*
Hypertension, Pulmonary*/diagnostic imaging
Hypertension, Pulmonary*/drug therapy
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/drug therapy
Humans ; Bevacizumab/therapeutic use ; Tomography, X-Ray Computed/methods ; Familial Primary Pulmonary Hypertension
Czasopismo naukowe
Tytuł:
Impact of diabetes mellitus on disease severity and patient survival in idiopathic pulmonary arterial hypertension: data from the Polish multicentre registry (BNP-PL).
Autorzy:
Jonas K; Department of Cardiac and Vascular Diseases, John Paul II Hospital in Krakow, Krakow, 31-202, Poland.; Pulmonary Circulation Centre, Department of Cardiac and Vascular Diseases, Faculty of Medicine, Jagiellonian University Medical College, Krakow, 31-008, Poland.; Center for Innovative Medical Education, Department of Medical Education, Faculty of Medicine, Jagiellonian University Medical College, Krakow, 30-688, Poland.
Kurzyna M; Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, Centre of Postgraduate Medical Education, Fryderyk Chopin Hospital in European Health Centre Otwock, Otwock, Poland.
Mroczek E; Clinic of Heart Diseases, Institute of Heart Diseases, University Clinical Hospital, Wrocław, Poland.
Chrzanowski Ł; Cardiology Department, Medical University of Lodz, Lodz, 91-347, Poland.
Mularek-Kubzdela T; Department of Cardiology, Poznan University of Medical Sciences, Poznan, 61-701, Poland.
Skoczylas I; 3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, 41-800, Poland.
Błaszczak P; Department of Cardiology, Cardinal Wyszynski Hospital, Lublin, 20-718, Poland.
Grześk G; Department of Cardiology and Clinical Pharmacology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Toruń, Poland.
Mizia-Stec K; First Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia in Katowice, Katowice, 40-635, Poland.
Kuśmierczyk B; Department of Congenital Heart Disease Institute of Cardiology, Warsaw, 04-628, Poland.
Kamiński K; Department of Cardiology, Medical University of Bialystok, Bialystok, 15-276, Poland.; Department of Population Medicine and Civilization Diseases Prevention, Medical University of Bialystok, Bialystok, 15-269, Poland.
Lewicka E; Department of Cardiology and Electrotherapy, Medical University of Gdansk, Gdansk, 80-211, Poland.
Peregud-Pogorzelska M; Department of Cardiology, Pomeranian Medical University, Szczecin, 70-111, Poland.
Tomaszewski M; Department of Cardiology, Medical University of Lublin, Lublin, 20-090, Poland.
Jacheć W; 2nd Department of Cardiology, School of Medicine with Dentistry Division in Zabrze, Medical University of Silesia in Katowice, Zabrze, 41-800, Poland.
Gąsior Z; Department of Cardiology, School of Health Sciences, Medical University of Cardiology in Katowice, Katowice, 40-635, Poland.
Pawlak A; Department of Invasive Cardiology, Polish Academy of Sciences, Mossakowski Medical Research Centre, Central Clinical Hospital of the Ministry of Interior, Warsaw, 02-507, Poland.
Ryczek R; Department of Cardiology and Internal Medicine, Military Institute of Medicine - National Research Institute, Warsaw, 04-141, Poland.
Pruszczyk P; Department of Internal Medicine and Cardiology with the Center for Diagnosis and Treatment of Venous Thromboembolism, Medical University of Warsaw, Warszawa, Poland.
Doboszyńska A; Pulmonary Department, University of Warmia and Mazury, Olsztyn, 10-357, Poland.
Widejko-Pietkiewicz K; Department of Cardiology, Copper Health Center, Lubin, 59-300, Poland.
Zabłocka W; Department of Cardiology, Provincial Specialist Hospital in Szczecin, Szczecin, Poland.
Waligóra M; Department of Cardiac and Vascular Diseases, John Paul II Hospital in Krakow, Krakow, 31-202, Poland.; Pulmonary Circulation Centre, Department of Cardiac and Vascular Diseases, Faculty of Medicine, Jagiellonian University Medical College, Krakow, 31-008, Poland.; Center for Innovative Medical Education, Department of Medical Education, Faculty of Medicine, Jagiellonian University Medical College, Krakow, 30-688, Poland.
Kopeć G; Department of Cardiac and Vascular Diseases, John Paul II Hospital in Krakow, Krakow, 31-202, Poland. .; Pulmonary Circulation Centre, Department of Cardiac and Vascular Diseases, Faculty of Medicine, Jagiellonian University Medical College, Krakow, 31-008, Poland. .
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2023 Jul 13; Vol. 22 (1), pp. 177. Date of Electronic Publication: 2023 Jul 13.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Hypertension, Pulmonary*/diagnosis
Hypertension, Pulmonary*/epidemiology
Hypertension, Pulmonary*/complications
Diabetes Mellitus*/diagnosis
Diabetes Mellitus*/epidemiology
Adult ; Humans ; Familial Primary Pulmonary Hypertension/diagnosis ; Prospective Studies ; Poland/epidemiology ; Prognosis ; Patient Acuity ; Registries
Czasopismo naukowe
Tytuł:
Reverse Potts for the Treatment of Severe Idiopathic Pulmonary Hypertension in Children.
Autorzy:
Castro MF; Department of Internal Medicine, Hospital Vila da Serra, Nova Lima, Minas Gerais, Brazil.
Oliveira EC; Department of Internal Medicine, Hospital Vila da Serra, Nova Lima, Minas Gerais, Brazil.
Nunes MCP; Department of Internal Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Oliveira C; Department of Cardiac Surgery, Hospital Vila da Serra, Nova Lima, Minas Gerais, Brazil.
Almeida MGC; Department of Internal Medicine, Hospital Vila da Serra, Nova Lima, Minas Gerais, Brazil.
Barbosa JAA; Department of Pediatric Cardiology, Hospital Vila da Serra, Nova Lima, Minas Gerais, Brazil.; Department of Pediatric Cardiology, Hospital Felicio Rocho, Belo Horizonte, Minas Gerais, Brazil.
Pokaż więcej
Źródło:
Brazilian journal of cardiovascular surgery [Braz J Cardiovasc Surg] 2023 Jul 04; Vol. 38 (4), pp. e20220320. Date of Electronic Publication: 2023 Jul 04.
Typ publikacji:
Case Reports
MeSH Terms:
Pulmonary Artery*/surgery
Hypertension, Pulmonary*/drug therapy
Hypertension, Pulmonary*/surgery
Child ; Humans ; Familial Primary Pulmonary Hypertension/surgery ; Anastomosis, Surgical ; Aorta, Thoracic/surgery
Raport
Tytuł:
Types of milk consumed and risk of essential hypertension: A 2-sample Mendelian randomization analysis.
Autorzy:
Shi Z; Institute of Population and Health, College of Life Sciences, Northwest University, Xi'an, 710069, P. R. China.
Zhao Z; Institute of Population and Health, College of Life Sciences, Northwest University, Xi'an, 710069, P. R. China.
Zhu P; Institute of Population and Health, College of Life Sciences, Northwest University, Xi'an, 710069, P. R. China.
An C; Foundational and Translational Medical Research Center, Department of Allergy and General Surgery, Hohhot First Hospital, Hohhot 010030, P. R. China. Electronic address: acy_.
Zhang K; Institute of Population and Health, College of Life Sciences, Northwest University, Xi'an, 710069, P. R. China; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Medicine, Northwest University, Xi'an 710069, P. R. China. Electronic address: .
Pokaż więcej
Źródło:
Journal of dairy science [J Dairy Sci] 2023 Jul; Vol. 106 (7), pp. 4516-4523. Date of Electronic Publication: 2023 May 22.
Typ publikacji:
Journal Article
MeSH Terms:
Milk*
Hypertension*/genetics
Hypertension*/veterinary
Animals ; Mendelian Randomization Analysis/veterinary ; Genome-Wide Association Study/veterinary ; Essential Hypertension/veterinary ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Tytuł:
Comparative analysis of intracardiac neural structures in the aged rats with essential hypertension.
Autorzy:
Pauziene N; Lithuanian University of Health Sciences, Kaunas, Lithuania.
Ranceviene D; Lithuanian University of Health Sciences, Kaunas, Lithuania.
Rysevaite-Kyguoliene K; Lithuanian University of Health Sciences, Kaunas, Lithuania.
Inokaitis H; Lithuanian University of Health Sciences, Kaunas, Lithuania.
Saburkina I; Lithuanian University of Health Sciences, Kaunas, Lithuania.
Plekhanova K; Lithuanian University of Health Sciences, Kaunas, Lithuania.
Sabeckiene D; Lithuanian University of Health Sciences, Kaunas, Lithuania.
Sabeckis I; Lithuanian University of Health Sciences, Kaunas, Lithuania.
Martinaityte R; Lithuanian University of Health Sciences, Kaunas, Lithuania.
Pilnikovaite E; Lithuanian University of Health Sciences, Kaunas, Lithuania.
Pauza DH; Lithuanian University of Health Sciences, Kaunas, Lithuania.
Pokaż więcej
Źródło:
Anatomical record (Hoboken, N.J. : 2007) [Anat Rec (Hoboken)] 2023 Sep; Vol. 306 (9), pp. 2313-2332. Date of Electronic Publication: 2022 Nov 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hypertension*
Rats ; Animals ; Rats, Inbred WKY ; Rats, Inbred SHR ; Essential Hypertension ; Nerve Fibers, Myelinated ; Axons
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies